Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy and Safety of the Soricle for Subjective Tinnitus Relief

NCT: NCT07548320 · COMPLETED

NCT IDNCT07548320
StatusCOMPLETED
Start Date2025-03-10
Completion2025-09-08

Brief Summary

This study was conducted to evaluate the efficacy and safety of Soricle, a medical device combining transcutaneous vagus nerve stimulation and sound stimulation, in patients with subjective tinnitus. Participants were randomly assigned to either the active treatment group or a sham control group in a double-blind manner. The device was used daily for 8 weeks. The primary objective was to assess the improvement in tinnitus symptoms, and safety was evaluated throughout the study period.

Frequently Asked Questions

What is Efficacy and Safety of the Soricle for Subjective Tinnitus Relief?

Efficacy and Safety of the Soricle for Subjective Tinnitus Relief is a clinical trial registered under NCT07548320. Current status: COMPLETED.

What is the status of NCT07548320?

The current status of NCT07548320 (Efficacy and Safety of the Soricle for Subjective Tinnitus Relief) is: COMPLETED.

When did Efficacy and Safety of the Soricle for Subjective Tinnitus Relief start?

Efficacy and Safety of the Soricle for Subjective Tinnitus Relief started on 2025-03-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.